These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35293607)

  • 41. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
    Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
    Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Lin K; Huang Q; Zeng J; Ding Z; Wang L; Chen Z; Guo P; Zeng Y; Zhou W; Liu J
    Dig Dis Sci; 2021 Dec; 66(12):4545-4556. PubMed ID: 33723698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma.
    Hayashi M; Yamada S; Takano N; Okamura Y; Takami H; Inokawa Y; Sonohara F; Tanaka N; Shimizu D; Hattori N; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    In Vivo; 2021; 35(3):1749-1760. PubMed ID: 33910859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
    Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
    Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
    Li SP; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
    Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH
    Updates Surg; 2022 Aug; 74(4):1345-1352. PubMed ID: 34374920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
    Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
    Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Insulin Treatment on Prognosis of non-B non-C Hepatocellular Carcinoma After Hepatectomy.
    Amemiya H; Matsuda M; Saito R; Hosomura N; Kawaida H; Kono H; Akaike H; Kawaguchi Y; Sudo M; Ichikawa D
    Anticancer Res; 2021 Jan; 41(1):317-326. PubMed ID: 33419826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
    Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
    Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
    Ma WJ; Wang HY; Teng LS
    World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy.
    Zhang J; Qin SD; Li Y; Lu F; Gong WF; Zhong JH; Ma L; Zhao JF; Zhan GH; Li PZ; Song B; De Xiang B
    World J Surg Oncol; 2022 Oct; 20(1):346. PubMed ID: 36258212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.
    Zhang XF; Lai EC; Kang XY; Qian HH; Zhou YM; Shi LH; Shen F; Yang YF; Zhang Y; Lau WY; Wu MC; Yin ZF
    Ann Surg Oncol; 2011 Aug; 18(8):2218-23. PubMed ID: 21336512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.
    Zhu WJ; Huang CY; Li C; Peng W; Wen TF; Yan LN; Li B; Wang WT; Xu MQ; Yang JY; Jiang L
    Asian Pac J Cancer Prev; 2013; 14(12):7101-6. PubMed ID: 24460258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors in hepatocellular carcinoma patients with Child-Pugh A liver function after hepatectomy: Not related to the surgical approach.
    Wei S; Yang M; Geng X; Xiong Q; Hou H; Zhou D; Cui X
    Ann Hepatol; 2022 Jan; 27 Suppl 1():100580. PubMed ID: 34788657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histological differentiation predicts post-liver transplantation survival time.
    Li WX; Li Z; Gao PJ; Gao J; Zhu JY
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.